NCT04004910
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1|Phase 2
Drug Category: Chemotherapy, Other
Key Eligibility Criteria:
Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes:
Exclusions: Patients with leptomeningeal disease or symptomatic CNS metastases that are neurologically unstable or require treatment- see trial for details
https://ClinicalTrials.gov/show/NCT04004910